Wall Street brokerages expect CME Group Inc (NASDAQ:CME) to post $1.62 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have issued estimates for CME Group’s earnings, with estimates ranging from $1.53 to $1.71. CME Group reported earnings per share of $1.77 in the same quarter last year, which suggests a negative year-over-year growth rate of 8.5%. The company is scheduled to issue its next earnings report on Thursday, February 13th.
According to Zacks, analysts expect that CME Group will report full year earnings of $6.87 per share for the current financial year, with EPS estimates ranging from $6.78 to $6.99. For the next year, analysts anticipate that the firm will post earnings of $7.40 per share, with EPS estimates ranging from $7.06 to $7.75. Zacks’ earnings per share calculations are an average based on a survey of research firms that that provide coverage for CME Group.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same period last year, the firm posted $1.45 EPS. CME Group’s revenue for the quarter was up 41.3% compared to the same quarter last year.
A number of equities analysts have issued reports on CME shares. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Citigroup raised their price target on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. UBS Group raised their price target on shares of CME Group from $218.00 to $221.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 4th. Finally, Oppenheimer started coverage on shares of CME Group in a research report on Monday, September 16th. They set an “outperform” rating and a $234.00 price target for the company. Three research analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $207.42.
In related news, CEO Terrence A. Duffy sold 39,309 shares of CME Group stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $202.38, for a total value of $7,955,355.42. Following the sale, the chief executive officer now owns 46,684 shares of the company’s stock, valued at approximately $9,447,907.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronald A. Pankau sold 300 shares of CME Group stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $199.02, for a total transaction of $59,706.00. Following the completion of the sale, the director now directly owns 3,906 shares in the company, valued at approximately $777,372.12. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Buckingham Asset Management LLC grew its stake in CME Group by 1.4% in the 2nd quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock valued at $700,000 after acquiring an additional 49 shares during the period. IHT Wealth Management LLC grew its stake in CME Group by 1.1% in the 2nd quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock valued at $855,000 after acquiring an additional 50 shares during the period. Covington Capital Management grew its stake in CME Group by 2.5% in the 3rd quarter. Covington Capital Management now owns 2,050 shares of the financial services provider’s stock valued at $433,000 after acquiring an additional 50 shares during the period. Pitcairn Co. boosted its stake in CME Group by 2.3% during the 2nd quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock worth $435,000 after purchasing an additional 51 shares during the last quarter. Finally, Cetera Investment Advisers boosted its stake in CME Group by 3.4% during the 3rd quarter. Cetera Investment Advisers now owns 1,668 shares of the financial services provider’s stock worth $351,000 after purchasing an additional 55 shares during the last quarter. 84.27% of the stock is currently owned by hedge funds and other institutional investors.
CME traded up $1.45 during trading on Friday, reaching $204.59. 891,892 shares of the company’s stock were exchanged, compared to its average volume of 1,174,438. CME Group has a 1 year low of $161.05 and a 1 year high of $224.91. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $73.36 billion, a P/E ratio of 30.00, a price-to-earnings-growth ratio of 4.04 and a beta of 0.17. The company’s fifty day simple moving average is $203.13 and its 200-day simple moving average is $205.64.
The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Tuesday, December 10th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.47%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: How To Calculate Debt-to-Equity Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.